๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

12 recruiting trials

for Atypical Hemolytic Uremic Syndrome

Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS NCT07308574Phase 412 sites๐Ÿ“ Bunkyล City๐Ÿ“ Hirakata-shi๐Ÿ“ Iruma-Gun Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS NCT05795140Phase 39 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Rio de Janeiro๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptcaopan 200 mg Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) NCT05935215Phase 331 sites๐Ÿ“ Nanjing๐Ÿ“ Beijing๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptacopan Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases NCT05996731NA1 site๐Ÿ“ Ranica Mario Negri Institute for Pharmacological Research ยท Tests: Skin biopsy Ravulizumab Outcomes in Polish Patients With aHUS NCT07399730n/a10 sites๐Ÿ“ Gdansk๐Ÿ“ Katowice๐Ÿ“ Katowice AstraZeneca ยท Tests: Ravulizumab Atypical Hemolytic-Uremic Syndrome (aHUS) Registry NCT01522183n/a141 sites๐Ÿ“ Aurora๐Ÿ“ Washington D.C.๐Ÿ“ Gainesville Alexion Pharmaceuticals, Inc. Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy NCT05805202NA1 site๐Ÿ“ Ranica Mario Negri Institute for Pharmacological Research ยท Tests: Blood sampling and urine analysis Study of Ultomirisยฎ (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites๐Ÿ“ Boston๐Ÿ“ Melbourne๐Ÿ“ Paris Alexion Pharmaceuticals, Inc. ยท Tests: Ultomiris Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome NCT05726916Phase 31 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Solirisยฎ, Renin angiotensin system blockers Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium NCT04745195n/a1 site๐Ÿ“ Maastricht Maastricht University Medical Center National Registry of Rare Kidney Diseases NCT06065852n/a1 site๐Ÿ“ Bristol UK Kidney Association
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy